Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Minoxidil effectively treats female pattern hair loss.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.